Developing ways of reducing allograft immunogenicity.
D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology*; D004285:Dogs; D006084:Graft Rejection / Q000187:drug effects*; D006085:Graft Survival / Q000187:drug effects; D006087:Graft vs Host Reaction; D006801:Humans; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000494:pharmacology*; D051379:Mice; D051381:Rats; D014181:Transplantation Immunology / Q000187:drug effects*; D014184:Transplantation, Homologous
D003520:Cyclophosphamide; D008775:Methylprednisolone